Sort By
Strength & Pharmacopoeial GradeAmoxicillin Trihydrate BP 875 mg & Potassium Clavulanate BP 125 mg is a fixed-dose antibacterial combination intended for oral tablet formulations. Each stated dose provides amoxicillin equivalent to 875 mg as amoxicillin trihydrate and clavulanic acid equivalent to 125 mg as potassium clavulanate. Pharmaceutical and institutional buyers should verify the finished-product specification, batch certificate of analysis (COA), registration status and applicable supply documentation before procurement.Composition & Product CharacteristicsThe formulation combines a penicillin-class antibacterial, amoxicillin, with clavulanic acid supplied as potassium clavulanate, a beta-lactamase inhibitor. Procurement assessment should cover identity, assay, related substances, dissolution, microbial quality, tablet characteristics and packaging integrity against the approved specification. Excipients, storage conditions, pack configuration and market-specific labelling should be confirmed from the manufacturerâs technical dossier and batch documentation.
Min. Order: 1 Unit
GST

Looking for “Aciclavcare Tablets”
Tell us your requirement & get the best quotes!
Reach Global
Suppliers
Accurate Business
Customized Services
For Buyers